Approaches to the treatment of mitochondrial diseases

Muscle and Nerve

Volumn 34, Issue 3, 2006, Pages 265-283

  DiMauro, Salvatore ^a   Hirano, Michio ^a   Schon, Eric A ^a  

^a 4 420 College of Physicians and Surgeons ^*  (United States)

Author keywords

Exercise; Gene shifting; Genetic counseling; Ooplasmic transfer; Oxygen radical scavenging; Palliative therapy; Preimplantation diagnosis; Supplementation therapy

Indexed keywords

ANTICONVULSIVE AGENT; CARNITINE; CELL NUCLEUS DNA; MITOCHONDRIAL DNA; REACTIVE OXYGEN METABOLITE; RESTRICTION ENDONUCLEASE; UBIDECARENONE;

CARNITINE DEFICIENCY; DEGENERATIVE DISEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENDOCRINE DISEASE; GENE EXPRESSION; GENE MUTATION; GENE THERAPY; GENETIC COUNSELING; GENETIC ENGINEERING; GENOME; GERM LINE; GOOD CLINICAL PRACTICE; HETEROPLASMY; HUMAN; METABOLITE; MUTANT; PALLIATIVE THERAPY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RESPIRATORY CHAIN; RESPIRATORY FUNCTION; REVIEW; TREATMENT INDICATION; VERTICAL TRANSMISSION; WILD TYPE;

ACIDOSIS, LACTIC; GENE THERAPY; HUMANS; MITOCHONDRIAL DISEASES;

EID: 33748089976     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.20598     Document Type: Review

References (128)

1. Allen RJ, DiMauro S, Coulter DL, Papadimitriou A, Rothenberg SP. Kearns-Sayre syndrome with reduced plasma and cerebrospinal fluid folate. Ann Neurol 1983;13:679-682.
2. Andreu AL, Hanna MG, Reichmann H, Bruno C, Penn AS, Tanji K, et al. Exercise intolerance due to mutations in the cytochrome b gene of mitochondrial DNA. N Engl J Med 1999;341:1037-1044.
3. Andrews RM, Griffiths PG, Chinnery PF, Turnbull DM. Evaluation of bupivacaine-induced muscle regeneration in the treatment of ptosis in patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome. Eye 1999;13:769-772.
4. Argov Z, Bank WJ, Maris J, Eleff S, Kennaway NG, Olson RE, et al. Treatment of mitochondrial myopathy due to complex III deficiency with vitamins K3 and C: A 31P-NMR follow-up study. Ann Neurol 1986;19:598-602.
5. Aurẃ K, Benoist JF, Ogier de Baulny H, Romero NB, Rigal O, Lombes A. Progression despite replacement of a myopathic form of coenzyme Q10 defect. Neurology 2004;63:727-729.
6. Bai Y, Hajek P, Chomyn A, Chan E, Seo BB, Matsuno-Yagi A, et al. Lack of complex I activity in human cells carrying a mutation in MtDNA-encoded ND4 subunit is corrected by the Saccharomyces cerevisiae NADH-quinone oxidoreductase (NDI1) gene. J Biol Chem 2001;276:38808-38813.
7. Baker SK, Tarnopolsky MA. Targeting cellular energy production in neurological disorders. Expert Opin Invest Drugs 2003;12:1-24.
8. Barritt JA, Brenner CA, Malter HE, Cohen J. Mitochondria in human offspring derived from ooplasmic transplantation. Hum Reprod 2001;16:513-516.
9. Bayona-Bafaluy MP, Blits B, Battersby BJ, Shoubridge EA, Moraes CT. Rapid directional shift of mitochondrial DNA heteroplasmy in animal tissues by a mitochondrially targeted restriction endonuclease. Proc Natl Acad Sci USA 2005;102: 14392-14397.
10. Bicknese AR, May W, Hickey WF, Dodson WE. Early childhood hepatocerebral degeneration misdiagnosed as valproate hepatotoxicity. Ann Neurol 1992;32:767-775.
11. Bindoff L. Mitochondrial gastroenterology. In: DiMauro S, Hirano M, Schon EA, editors. Mitochondrial medicine. London: Informa Healthcare; 2006. p 143-159.
12. Blok RB, Gook DA, Thorburn DR, Dahl H-HM. Skewed segregation of the mtDNA nt 8993 (T>G) mutation in human oocytes. Am J Hum Genet 1997;60:1495-1501.
13. Bohlega S, Tanji K, Santorelli FM, Hirano M, al-Jishi A, DiMauro S. Multiple mitochondrial DNA deletions associated with autosomal recessive ophthalmoplegia and severe cardiomyopathy. Neurology 1996;46:1329-1334.
14. Boitier E, Degoul F, Desguerre I, Charpentier C, Francois D, Ponsot G, et al. A case of mitochondrial encephalomyopathy associated with a muscle coenzyme Q10 deficiency. J Neurol Sci 1998;156:41-46.
15. Bonnet D, Rustin P, Rotig A, Le Bidois J, Munnich A, Vouhé P, et al. Heart transplantation in children with mitochondrial cardiomyopathy. Heart 2001;86:570-573.
16. Brenner CA, Barritt JA, Willadsen S, Cohen J. Mitochondrial DNA heteroplasmy after human ooplasmic transplantation. Fertil Steril 2000;74:573-578.
17. Brini M, Pinton P, King MP, Davidson MM, Schon EA, Rizzuto R. A calcium signaling defect in the pathogenesis of a mitochondrial DNA inherited oxidative phosphorylation deficiency. Nature Med 1999;5:951-954.
18. Carelli V, Barboni P, Sadun AA. Mitochondrial ophthalmology. In: DiMauro S, Hirano M, Schon EA, editors. Mitochondrial medicine. London: Informa Healthcare; 2006. p 105-142.
19. Carroll PV, Umpleby AM, Albany E, Jackson NC, Morgan-Hughes JA, Sonksen PH, et al. Growth hormone therapy may benefit protein metabolism in mitochondrial encephalomyopathy. Clin Endocrinol 1997;47:113-117.
20. Chinnery PF, Taylor RW, Diekert K, Lill R, Turnbull DM, Lightowlers RN. Peptic nucleic acid delivery to human mitochondria. Gene Therapy 1999;6:1919-1928.
21. Chinnery PF, DiMauro S, Shanske S, Schon EA, Zeviani M, Mariotti C, et al. Risk of developing a mitochondrial DNA deletion disorder. Lancet 2004;364:592-595.
22. Chinnery PF, Griffiths TD. Mitochondrial otology. In: DiMauro S, Hirano M, Schon EA, editors. Mitochondrial medicine. London: Informa Healthcare; 2006. p 161-177.
23. Clark KM, Bindoff LA, Lightowlers RN, Andrews RM, Griffiths PG, Johnson MA, et al. Reversal of a mitochondrial DNA defect in human skeletal muscle. Nature Genet 1997; 16:222-224.
24. Crameri RM, Langberg H, Magnusson P, Jensen CH, Schroder HD, Diesen JL, et al. Changes in satellite cells in human skeletal muscle after a single bout of high intensity exercise. J Physiol 2004;558:333-340.
25. De Vivo DC, DiMauro S. Mitochondrial diseases. In: Swaiman KF, Ashwal S, editors. Pediatric neurology: principles & practice. Volume 1. St. Louis: Mosby; 1999. p 494-509.
26. Di Giovanni S, Mirabella M, Spinazzola A, Crociani P, Silvestri G, Broccolini A, et al. Coenzyme Q10 reverses pathological phenotype and reduces apoptosis in familial CoQ10 deficiency. Neurology 2001;57:515-518.
27. DiMauro S, Schon EA. Mitochondrial respiratory-chain diseases. N Engl J Med 2003;348:2656-2668.
28. DiMauro S, Hirano M, Kaufmann P, Mann JJ. Mitochondrial psychiatry. In: DiMauro S, Hirano M, Schon EA, editors. Mitochondrial medicine. London: Informa Healthcare; 2006. p 261-277.
29. Dougados M, Zitoun J, Laplane D, Castaigne P. Folate metabolism disorder in Kearns-Sayre syndrome. Ann Neurol 1983;13:687
30. Edmonds JL. Surgical and anesthetic management of patients with mitochondrial dysfunction. Mitochondrion 2004; 4:543-548.
31. Eells JT, Henry MM, Summerfelt P, Wong-Riley MTT, Buchmann EV. Kane N, et al. Therapeutic photobiomodulation for methanol-induced retinal toxicity. Proc Natl Acad Sci USA 2003;100:3439-3444.
32. Eleff S, Kennaway NG, Buist NR, Darley-Usmar VM, Capaldi RA, Bank WJ, et al. 31P-NMR study of improvement in oxidative phosphorylation by vitamins K3 and C in a patient with a defect in electron transport at complex III in skeletal muscle. Proc Natl Acad Sci USA 1984;81:3529-3533.
33. Flierl A, Jackson C, Cottrell B, Murdock D, Seibel P, Wallace DC. Targeted delivery of DNA to the mitochondrial compartment via import sequence-conjugated peptide nucleic acid. Mol Ther 2003;7:550-557.
34. Flierl A, Chen YT, Coskun PE, Samulski RJ, Wallace DC. Adeno-associated virus-mediated gene transfer of the heart/muscle adenine nucleotide translocator (ANT) in mouse. Gene Ther 2005;12:570-578.
35. Freisinger P, Horvath R, Macmillan C, Peters J, Jaksch M. Reversion of hypertrophic cardiomyopathy in a patient with deficiency of the mitochondrial copper binding protein Sco2: is there a potential effect of copper? J Inher Metab Dis 2004;27:67-79.
36. leu(CUN) mtDNA point mutation in a sporadic patient with mitochondrial encephalomyopathy segregates rapidly in skeletal muscle and suggests an approach to therapy. Hum Mol Genet 1996;5:1835-1840.
37. Gattermann N, Zanssen S. Mitochondrial hematology and oncology. In: DiMauro S, Hirano M, Schon EA, editors. Mitochondrial medicine. London: Informa Healthcare; 2006. p 209-239.
38. Gironi M, Lamperti C, Nemni R, Moggio M, Comi GP, Guerini FR, et al. Late-onset cerebellar ataxia with hypogonadism and muscle coenzyme Q10 deficiency. Neurology 2004;62:818-820.
39. Grad LI, Sayles LC, Lemire BD. Introduction of an additional pathway for lactate oxidation in the treatment of lactic acidosis and mitochondrial dysfunction in Caenorhabditis elegans. Proc Natl Acad Sci USA 2005;102:18367-18372.
40. Guy J, Qi X, Pallotti F, Schon EA, Manfredi G, Carelli V, et al. Rescue of a mitochondrial deficiency causing Leber hereditary optic neuropathy. Ann Neurol 2002;52:534-542.
41. Hakkaart GA, Dassa EP, Jacobs HT, Rustin P. Allotopic expression of a mitochondrial alternative oxidase confers cyanide resistance to human cell respiration. EMBO Rep 2006; 7:341-345.
42. Hargreaves IP, Sheena Y, Land JM, Heales SJR. Glutathione deficiency in patients with mitochondrial diseases: Implications for pathogenesis and treatment. J Inher Metab Dis 2005;28:81-88.
43. Hasegawa H, Matsuoka T, Goto I, Nonaka I. Strongly succinate dehydrogenase-reactive blood vessels in muscles from patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. Ann Neurol 1991;29: 601-605.
44. Hassainen T. Mitochondrial dysfunction in liver disease and organ transplantation. Mitochondrion 2004;4:609-620.
45. Haydar NA, Conn HL, Afifi A, Wakid N, Ballas S, Fawaz K. Severe hypermetabolism with primary abnormality of skeletal muscle mitochondria. Ann Int Med 1971;74:548-558.
46. Hays AP, Oskoui M, Tanji K, Kaufmann P, Bonilla E. Mitochondrial neurology. II: Myopathies and peripheral neuropathies. In: DiMauro S, Hirano M, Schon EA, editors. Mitochondrial medicine. London: Informa Healthcare; 2006. p 45-74.
47. Hirano M, DiMauro S. ANT1, Twinkle, POLG, and TP: new genes open our eyes to ophthalmoplegia. Neurology 2001; 57:2163-2165.
48. Hirano M, Kaufmann P, De Vivo DC, Tanji K. Mitochondrial neurology. I: Encephalopathies. In: DiMauro S, Hirano M, Schon EA, editors. Mitochondrial medicine. London: Informa Healthcare; 2006. p 27-44.
49. Horvath R, Scneiderat P, Schoser BGH, Gempel K, Neuen-Jacob E, Ploger H, et al. Coenzyme Q10 deficiency and isolated myopathy. Neurology 2006;66:253-255.
50. Iuso A, Scacco S, Piccoli C, Bellomo F, Petruzzella V, Trentadue R, et al. Dysfunction of cellular oxidative metabolism in patients with mutations in the NDUFS1 and NDUFS4 genes of complex I. J Biol Chem 2006;281:10374-10380.
51. Jaksch M, Paret C, Stucka R, Horn N, Muller-Hocker J, Horvath R, et al. Cytochrome c oxidase deficiency due to mutations in SCO2, encoding a mitochondrial copper-binding protein, is rescued by copper in human myoblasts. Hum Mol Genet 2001;10:3025-3035.
52. James AM, Cocheme HM, Smith RAJ, Murphy MP. Interactions of mitochondria-targeted and untargeted ubiquinones with the mitochondrial respiratory chain and reactive oxygen species. J Biol Chem 2005;280:21295-21312.
53. Karadimas CL, Greenstein P, Sue CM, Joseph JT, Tanji K, Haller RG, et al. Recurrent myoglobinuria due to a nonsense mutation in the COX I gene of mtDNA. Neurology 2000;55: 644-649.
54. Kaufmann P, Shungu D, Sano MC, Engelstad K, Mitsis E, Mao X, et al. Cerebral lactic acidosis correlates with neurological impairment in MELAS. Neurology 2004;62: 1297-1302.
55. Kaufmann P, Engelstad K, Wei Y-H, Sano MC, Shungu D, Millar WS, et al. Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial. Neurology 2006;66:324-330.
56. Keightley JA, Anitori R, Burton MD, Quan F, Buist NRM, Kennaway NG. Mitochondrial encephalomyopathy and complex III deficiency associated with a stop-codon mutation in the cytochrome b gene. Am J Hum Genet 2000;67:1400-1410.
57. Kennaway NG, Buist NR, Darley Usmar VM, Papadimitriou A, DiMauro S, Kelley RI, et al. Lactic acidosis and mitochondrial myopathy associated with deficiency of several components of complex III of the respiratory chain. Pediatr Res 1984;18:991-999.
58. King MP, Attardi G. Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science 1989;246:500-503.
59. Klopstock T, Schlamp V, Schmidt F, Gekeler F, Hartard M, Pongratz D, et al. Creatine monohydrate in mitochondrial diseases: a double-blind, placebo-controlled, cross-over study in 16 patients with progressive external ophthalmoplegia or mitochondrial myopathy. Neurology 1999;52:A543-A544.
60. Koga Y, Akita Y, Nishioka J, Yatsuga S, Povalko N, Tanabe Y, et al. L-arginine improves the symptoms of strokelike episodes in MELAS. Neurology 2005;64:710-712.
61. Kolesnikova OA, Entelis NS, Mireau H, Fox TD, Martin RP, Tarassov IA. Suppression of mutations in mitochondrial DNA by tRNAs imported from the cytoplasm. Science 2000; 289:1931-1933.
62. Kolesnikova OA, Entelis NS, Jacquin-Becker C, Goltzene F, Chrzanowska-Lightowlers ZM, Lightowlers RN, et al. Nuclear DNA-encoded tRNAs targeted into mitochondria can rescue a mitochondrial DNA mutation associated with the MERRF syndrome in cultured human cells. Hum Mol Genet 2004; 13:2519-2534.
63. Kornblum C, Broicher R, Walther E, Seibel P, Reichmann H, Klockgether T, et al. Cricopharyngeal achalasia is a common cause of dysphagia in patients with mtDNA deletions. Neurology 2001;56:1409-1412.
64. Lalani S, Vladutiu GD, Plunkett K, Lotze TE, Adesina AM, Scaglia F. Isolated mitochondrial myopathy associated with muscle coenzyme Q10 deficiency. Arch Neurol 2005;62:317-320.
65. Lamperti C, Naini A, Hirano M, De Vivo DC, Bertini E, Servidei S, et al. Cerebellar ataxia and coenzyme Q10 deficiency. Neurology 2003;60:1206-1208.
66. Manfredi G, Gupta N, Vazquez-Memije ME, Sadlock JE, Spinazzola A, De Vivo DC, et al. Oligomycin induces a decrease in the cellular content of a pathogenic mutation in the human mitochondrial ATPase 6 gene. J Biol Chem 1999; 274:9386-9391.
67. Manfredi G, Fu J, Ojaimi J, Sadlock JE, Kwong JQ, Guy J, et al. Rescue of a deficiency in ATP synthesis by transfer of MTATP6, a mitochondrial DNA-encoded gene, to the nucleus. Nature Genet 2002;30:394-399.
68. Manfredi G, Beal MF. Poison and antidote: a novel model to study pathogenesis and therapy of LHON. Ann Neurol 2004; 56:171-172.
69. Marriage BJ, Clandinin MT, Macdonald IM, Glerum DM. Cofactor treatment improves ATP synthetic capacity in patients with oxidative phosphorylation disorders. Mol Genet Metab 2004;81:263-272.
70. McGregor A, Smith PM, Ross GF, Taylor RW, Turnbull DM, Lightowlers RN. Bridging PNAs can bind preferentially to a deleted mitochondrial DNA template but replication by mitochondrial DNA polymerase gamma in vitro is not impaired. Biochim Biophys Acta 2003;1629:73-83.
71. Melancini P, Gambino A, Caforio A, Barchitta A, Valente ML, Angelini A, et al. Heart transplantation in patients with inherited myopathies associated with end-stage cardiomyopathy: molecular and biochemical defects on cardiac and skeletal muscle. Transplant Proc 2001;33:1596-1599.
72. Millhouse-Flourie TJ. Physical, occupational, respiratory, speech, equine, and pet therapies for mitochondrial disease. Mitochondrion 2004;4:549-558.
73. Musumeci O, Naini A, Slonim AE, Scavin N, Hadjigeorgiou GL, Krawiecki N, et al. Familial cerebellar ataxia with muscle coenzyme Q10 deficiency. Neurology 2001;56:849-855.
74. Nagley P, Farrell LB, Gearing DP, Nero D, Meltzer G, Devenish RJ. Assembly of functional proton-translocating ATPase complex in yeast mitochondria with cytoplasmically synthesised subunit 8, a polypeptide normally encoded by the organelle. Proc Natl Acad Sci USA 1988;85:2091-2095.
75. Naini A, Kaufmann P, Shanske S, Engelstad K, De Vivo DC, Schon EA. Hypocitrullinemia in patients with MELAS: an insight into the "MELAS paradox." J Neurol Sci 2005;229: 187-193.
76. Nishino I, Spinazzola A, Hirano M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 1999;283:689-692.
77. Ogasahara S, Engel AG, Frens D, Mack D. Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy. Proc Natl Acad Sci USA 1989;86:2379-2382.
78. Oguro H, Iijima K, Takahashi K, Nagai A, Bokura H, Yamaguchi S, et al. Successful treatment with succinate in a patient with MELAS. Intern Med 2004;43:427-431.
79. Ohama E, Ohara S, Ikuta F, Tanaka K, Nishizawa M, Miyatake T. Mitochondrial angiopathy in cerebral blood vessels of mitochondrial encephalomyopathy. Acta Neuropathol 1987;74:226-233.
80. Ojaimi J, Pan J, Santra S, Snell WJ, Schon EA. An algal nucleus-encoded subunit of mitochondrial ATP synthase rescues a defect in the analogous human mitochondrial-encoded subunit. Mol Biol Cell 2002;13:3836-3844.
81. Petruzzella V, Moraes CT, Sano MC, Bonilla E, DiMauro S, Schon EA. Extremely high levels of mutant mtDNAs colocalize with cytochrome c oxidase-negative ragged-red fibers in patients harboring a point mutation at nt 3243. Hum Mol Genet 1994;3:449-454.
82. Pineda M, Ormazabal A, Lopez-Gallardo E, Nascimiento A, Solano A, Herrero MD, et al. Cerebral folate deficiency and leukoencephalopathy caused by a mitochondrial DNA deletion. Ann Neurol 2006;59:394-398.
83. Qi X, Lewin AS, Hauswirth WW, Guy J. Optic neuropathy induced by reductions in mitochondrial superoxide dismutase. Invest Ophthalmol Vis Sci 2003;44:1088-1096.
84. Qi X, Lewin AS, Hauswirth WW, Guy J. Suppression of complex I gene expression induces optic neuropathy. Ann Neurol 2003;53:198-205.
85. Qi X, Lewin AS, Sun L, Hauswirth WW, Guy J. SOD2 gene transfer protects against optic neuropathy induced by deficiency of complex I. Ann Neurol 2004;56:182-191.
86. Quinzii C, Kattah AG, Naini A, Akman HO, Mootha VK, DiMauro S, et al. Coenzyme Q deficiency and cerebellar ataxia associated with an aprataxin mutation. Neurology 2005;64:539-541.
87. Quinzii C, Naini A, Salviati L, Trevisson E, Navas P, DiMauro S, et al. A mutation in para-hydoxybenzoate-polyprenyl transferase (COQ2) causes primary coenzyme Q10 deficiency. Am J Hum Genet 2006;78:345-349.
88. Rahman S, Hargreaves I, Clayton P, Heales S. Neonatal presentation of coenzyme Q10 deficiency. J Pediatr 2001; 139:456-458.
89. Rake JP, van Spronsen FJ, Visser G, Ruitenbeek W, Schweizer JJ, Bijleveld CMA, et al. End-stage liver disease as the only consequence of a mitochondrial respiratory chain deficiency: no contra-indication for liver transplantation. Eur J Pediatr 2000;159:523-526.
90. Rötig A, Appelkvist E-L, Geromel V, Chretien D, Kadhom N, Edery P, et al. Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency. Lancet 2000;356:391-395.
91. Rötig A, Niaudet P. Mitochondrial nephrology. In: DiMauro S, Hirano M, Schon EA, editors. Mitochondrial medicine. London: Informa Healthcare; 2006. p 197-207.
92. Sakuta R, Nonaka I. Vascular involvement in mitochondrial myopathy. Ann Neurol 1989;25:594-601.
93. Salviati L, Hernandez-Rosa E, Walker WF, Sacconi S, DiMauro S, Davidson MM. Copper supplementation restores cytochrome c oxidase activity in cultured cells from patients with SCO2 mutations. Biochem J 2002;363:321-327.
94. Salviati L, Sacconi S, Mancuso M, Otaegui D, Camano P, Marina A, et al. Mitochondrial DNA depletion and dGK gene mutations. Ann Neurol 2002;52:311-317.
95. Salviati L, Sacconi S, Murer L, Zacchello G, Franceschini L, Laverda AM, et al. Infantile encephalomyopathy and nephropathy with CoQ10 deficiency: a CoQ10-responsive condition. Neurology 2005;65:606-608.
96. Santra S, Gilkerson RW, Davidson MM, Schon EA. Ketogenic treatment reduces deleted mitochondrial DNAs in cultured human cells. Ann Neurol 2004;56:662-669.
97. Sato A, Kono T, Nakada K, Ishikawa K, Inoue S-I, Yonekawa H, et al. Gene therapy for progeny of mito-mice carrying pathogenic mtDNA by nuclear transplantation. Proc Natl Acad Sci USA 2005;102:16765-16770.
98. Schon EA. Appendix. In: DiMauro S, Hirano M, Schon EA, editors. Mitochondrial medicine. London: Informa Healthcare; 2006. p 329-335.
99. Seo BB, Nakamaru-Ogiso E, Cruz P, Flotte TR, Yagi T, Matsuno-Yagi A. Functional expression of the single subunit NADH dehydrogenase in mitochondria in vivo: a potential therapy for complex I deficiency. Hum Gene Ther 2004;15: 887-895.
100. Shoffner JM, Lott MT, Voljavec AS, Soueidan SA, Costigan DA, Wallace DC. Spontaneous Kearns-Sayre/chronic external ophthalmoplegia plus syndrome associated with a mtDNA deletion: a slip-replication model and metabolic therapy. Proc Natl Acad Sci 1989;86:7952-7956.
101. Shoubridge EA, Johns T, Karpati G. Complete restoration of a wild-type mtDNA genotype in regenerating muscle fibers in a patient with a tRNA point mutation and mitochondrial encephalomyopathy. Hum Mol Genet 1997;6:2239-2242.
102. Shults CW, Schapira AHV. A cue to queue for CoQ? Neurology 2001;57:375-376.
103. Sinnathurai AR, Raut V, Awa A, Magee A, Toner JG. A review of cochlear implantation in mitochondrial sensorineural hearing loss. Otol Neurol 2003;24:418-426.
104. Sobreira C, Hirano M, Shanske S, Keller RK, Haller RG, Davidson E, et al. Mitochondrial encephalomyopathy with coenzyme Q10 deficiency. Neurology 1997;48:1238-1243.
105. Spees JL, Olson SD, Whitney MJ, Prockop DJ. Mitochondrial transfer between cells can rescue aerobic respiration. Proc Natl Acad Sci USA 2006;103:1283-1288.
106. Spinazzola A, Marti R, Nishino I, Andreu AL, Naini A, Tadesse S, et al. Altered thymidine metabolism due to defects of thymidine phosphorylase. J Biol Chem 2002;277:4128-4132.
107. Stacpoole PW. The pharmacology of dichloroacetate. Metabolism 1989;38:1124-1144.
108. Steffann J, Frydman N, Gigarel N, Burlet P, Ray PF, Franchin R, et al. Analysis of mtDNA variant segregation during early human embryonic development: a tool for successful NARP preimplantation diagnosis. J Med Genet 2006;43:244-247.
109. Taanman JW, Muddle JR, Muntau AC. Mitochondrial DNA depletion can be prevented by dGMP and dAMP supplementation in a resting culture of deoxyguanosine kinase-deficient fibroblasts. Hum Mol Genet 2003;12:1839-1845.
110. Taivassalo T, Fu K, Johns T, Arnold D, Karpati G, Shoubridge EA. Gene shifting: a novel therapy for mitochondrial myopathy. Hum Mol Genet 1999;8:1047-1052.
111. Taivassalo T, Haller RG. Implications of exercise training in mtDNA defects-use or lose it? Biochim Biophys Acta 2004; 1659:221-231.
112. Taivassalo T, Haller RG. Exercise and training in mitochondrial myopathies. Med Sci Sports Exerc 2005;37:2094-2101.
113. Tanaka M, Borgeld HJ, Zhang J, Muramatsu S, Gong JS, Yoneda M, et al. Gene therapy for mitochondrial disease by delivering restriction endonuclease SmaI into mitochondria. J Biomed Sci 2002;9:534-541.
114. Tarnopolsky MA, Roy BD, MacDonald JR. A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies. Muscle Nerve 1997;20:1502-1509.
115. Tarnopolsky MA, Parise G. Direct measurement of high-energy phosphate compounds in patients with neuromuscular disease. Muscle Nerve 1999;22:1228-1233.
116. Taylor RW, Chinnery PF, Turnbull DM, Lightowlers RN. Selective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acids. Nature Genet 1997;15:212-215.
117. Tein I, DeVivo DC, Bierman F, Pulver P, DeMeirleir LJ, Cvitanovic-Sojat L, et al. Impaired skin fibroblast carnitine uptake in primary systemic carnitine deficiency manifested by childhood carnitine-responsive cardiomyopathy. Pediat Res 1990;28:247-255.
118. Tein I. Carnitine transport: pathophysiology and metabolism of known molecular defects. J Inher Metab Dis 2003; 26:147-169.
119. Templeton A. Ooplasmic transfer-proceed with care. N Engl J Med 2002;346:773-775.
120. Thorburn DR. Mitochondrial reproductive medicine. In: DiMauro S, Hirano M, Schon EA, editors. Mitochondrial medicine. London: Informa Healthcare; 2006. p 241-259.
121. Tieu K, Przedborski S. Mitochondrial dysfunction and neurodegenerative disorders. In: DiMauro S, Hirano M, Schon EA, editors. Mitochondrial medicine. London: Informa Healthcare; 2006. p 279-307.
122. Towbin JA. Mitochondrial cardiology. In: DiMauro S, Hirano M, Schon EA, editors. Mitochondrial medicine. London: Informa Healthcare: 2006. p 75-103.
123. Tranchant C, Mousson B, Mohr M, Dumoulin R, Welsh M, Weiss, C, et al. Cardiac transplantation in an incomplete Kearns-Sayre syndrome with mitochondrial DNA deletion. Neuromusc Disord 1993;3:561-566.
124. 2+ handling in human complex I deficiency. J Biol Chem 2004;279:40328-40336.
125. Wallace DC. The mitochondrial genome in human adaptive radiation and disease: on the road to therapeutics and performance enhancement. Gene 2005;354:169-180.
126. White SL, Shanske S, McGill JJ, Mountain H, Geraghty MT, DiMauro S, et al. Mitochondrial DNA mutations at nucleotide 8993 show a lack of tissue- or age-related variation. J Inner Metab Dis 1999;22:899-914.
127. Wong VA, Beckingsale PS, Oley CA, Sullivan TJ. Management of myogenic ptosis. Ophthalmology 2002;109:1023-1031.
128. Yialamas MA, Groop L, Mootha VK. Mitochondrial endocrinology. In: DiMauro S, Hirano M, Schon EA, editors. Mitochondrial medicine. London: Informa Healthcare; 2006. p 179-195.